Abatacept Retention Rates and Prognostic Factors of Retention in Patients with Rheumatoid Arthritis (RA) Treated in Canada: 2-Year Results from a Real-World Observational Study

被引：0
|
作者：
Haraoui, Boulos [1 ]
Choquette, Denis [2 ]
Bessette, Louis [3 ]
Khraishi, Majed [4 ]
Maoui, Meryem [5 ]
Heitzmann, Julia [6 ]
Connolly, Sean [5 ]
Alten, Rieke [7 ]
机构：
[1] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada
[2] Inst Rhumatol Montreal, Montreal, PQ, Canada
[3] Univ Laval, CHU Quebec, Dept Rheumatol, Quebec City, PQ, Canada
[4] Mem Univ Newfoundland, Dept Med, St John, NF, Canada
[5] Bristol Myers Squibb, Montreal, PQ, Canada
[6] Excelya, Boulogne, France
[7] Charite, Berlin, Germany
来源：
JOURNAL OF RHEUMATOLOGY | 2018年 / 45卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
收藏
页码：980 / 980
页数：1
相关论文
共 50 条
  • [31] DOES BODY MASS INDEX IMPACT LONG-TERM RETENTION WITH ABATACEPT IN PATIENTS WITH RA WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT? 2-YEAR RESULTS FROM A REAL-WORLD, INTERNATIONAL, PROSPECTIVE STUDY
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H.
    Nurmohamed, M.
    Benson, W.
    Burmester, G.
    Peter, H.
    Peichl, P.
    Pavelka, P.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 31 - 32
  • [32] A Real-World 2-Year Prospective Study of Medication Tapering in Patients with RA in Sustained Remission in the RHEUmatoid Arthritis Medication TAPering (RHEUMTAP) Cohort
    Tageldin, Mohamed
    Attur, Malavikalakshmi
    Wilson, Nicole
    Schorr, Rebecca
    Sharma, Tarun
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1686 - 1689
  • [33] Real-world observational study of patients with rheumatoid arthritis treated with baricitinib or tofacitinib in a tertiary hospital
    Guillen Benitez, Elena
    Sabate Gallego, Monica
    Ballarin Alins, Elena
    Espartal Lopez, Esther
    Lopez Lasanta, Maria
    Bosch Ferrer, Montserrat
    Artilagas Boixareu, Nuria
    Alerany Pardo, Carmen
    Danes Carreras, Immaculada
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 16 - 17
  • [34] Predictors of Real-World Treatment Sustainability in RA Patients Treated with Abatacept in Canada: Implications for Routine Care
    Pope, Janet E.
    Rampakakis, Emmanouil
    Sampalis, John S.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] Predictors of Real-World Treatment Sustainability in RA Patients Treated with Abatacept in Canada: Implications for Routine Care
    Pope, Janet
    Rampakakis, Emmanouil
    Sampalis, John
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1342 - 1343
  • [36] COMPARATIVE SAFETY OF ABATACEPT IN RHEUMATOID ARTHRITIS WITH COPD: A REAL-WORLD POPULATION-BASED OBSERVATIONAL STUDY
    Suissa, S.
    Ernst, P.
    Dell'Aniello, S.
    Shen, S.
    Simon, T. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 613 - 614
  • [37] Comparative safety of abatacept in rheumatoid arthritis with COPD: A real-world population-based observational study
    Suissa, Samy
    Hudson, Marie
    Dell'Aniello, Sophie
    Shen, Sophie
    Simon, Teresa A.
    Ernst, Pierre
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (03) : 366 - 372
  • [38] IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA
    Alten, R.
    Mariette, X.
    Flipo, R. M.
    Caporali, R.
    Buch, M. H.
    Patel, Y.
    Sanmarti, R.
    Marsal, S.
    Nurmohamed, M. T.
    Griffiths, H.
    Peichl, P.
    Bannert, B.
    Forster, A.
    Chartier, M.
    Connolly, S.
    Elbez, Y.
    Rauch, C.
    Khaychuk, V.
    Lozenski, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 108 - 108
  • [39] Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan
    Kuo, Ming-Chung
    Lin, Chien-Chin
    Lin, Hsuan-Yu
    Gau, Jyh-Pyng
    Wang, Ming-Chung
    Chang, Ming-Chih
    Chen, Tsung-Chih
    Yeh, Shih-Peng
    Chen, Yeu-Chin
    Huang, Cih-En
    Chiang, I-Ju
    Chung, Chu-Han
    Lee, Yee-Ming
    Ku, Fan-Chen
    Chang, Cheng-Shyong
    [J]. BLOOD, 2022, 140 : 9709 - 9710
  • [40] Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
    Uta Kiltz
    Petros P. Sfikakis
    Karl Gaffney
    Andreas Bounas
    Nicola Gullick
    Eric Lespessailles
    Jan Brandt-Juergens
    Rasho Rashkov
    Barbara Schulz
    Effie Pournara
    Piotr Jagiello
    [J]. Rheumatology and Therapy, 2022, 9 : 1129 - 1142
12345